Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × fludarabine × Clear all

Phase

Phase 1 6 Phase 1/2 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 84 Myelodysplastic Syndromes 65 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Leukemia, Lymphocytic, Chronic, B-Cell 53 Leukemia 47 Lymphoma, Non-Hodgkin 41 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 40 Multiple Myeloma 37 Lymphoma 37 Hodgkin Disease 35 Hematologic Neoplasms 29 Myeloproliferative Disorders 24 Melanoma 22 Lymphoma, Follicular 17 Recurrence 16 Lymphoma, Mantle-Cell 16 Lymphoma, Large B-Cell, Diffuse 15 Primary Myelofibrosis 14 Burkitt Lymphoma 14 Neoplasms 13 Lymphoma, B-Cell, Marginal Zone 13 Leukemia, Biphenotypic, Acute 13 Leukemia, Myelomonocytic, Chronic 12 Anemia, Refractory, with Excess of Blasts 12 Lymphoma, B-Cell 11 Hematologic Diseases 11 Graft vs Host Disease 11 Anemia, Aplastic 11 Skin Neoplasms 10 Ovarian Neoplasms 10

Interventions

Cisplatin 80 Fluorouracil 66 Paclitaxel 62 Radiotherapy 56 Oxaliplatin 51 Irinotecan 35 Docetaxel 34 Leucovorin 32 Carboplatin 30 Capecitabine 26 Radiation 25 Surgical Procedures, Operative 20 pembrolizumab 17 Drug Therapy 15 Bevacizumab 15 Cetuximab 14 Nivolumab 12 tislelizumab 11 Chemoradiotherapy 11 Albumin-Bound Paclitaxel 10 camrelizumab 9 S 1 (combination) 9 Neoadjuvant Therapy 9 Esophagectomy 9 nimotuzumab 8 durvalumab 8 Trastuzumab 8 Radiotherapy, Intensity-Modulated 7 Gefitinib 7 nedaplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01795976 2018-08-07

ATTACK-OG

The Christie NHS Foundation Trust

Phase 2 Terminated

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡